As reported in a research article, after implantation of an amplatzer device, the patient developed a tia.A residual shunt was also present.The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined an initial review of complaints data was reviewed as a component of the complaint handling risk review per wi (b)(4).The medical device problem and aho codes are consistent with the hazards/harms identified for this product family, and no new hazards or harms were identified.
|
It was reported in an article titled, "complications and mid-term outcome after percutaneous patent foramen ovale closure in patients with cryptogenic stroke" that on an unknown date, a cardioseal/starflex device was initially selected for implant.However, due to periprocedural complications, the device was removed.One month later, the patient was implanted with an amplatzer device.During the follow-up period, the patient developed a transient ischemic attack due to a residual shunt.No additional information was provided.
|